750 related articles for article (PubMed ID: 17129656)
21. Efficient hydrolysis of the chemical warfare nerve agent tabun by recombinant and purified human and rabbit serum paraoxonase 1.
Valiyaveettil M; Alamneh Y; Biggemann L; Soojhawon I; Doctor BP; Nambiar MP
Biochem Biophys Res Commun; 2010 Dec; 403(1):97-102. PubMed ID: 21040699
[TBL] [Abstract][Full Text] [Related]
22. Acetylcholinesterase active centre and gorge conformations analysed by combinatorial mutations and enantiomeric phosphonates.
Kovarik Z; Radić Z; Berman HA; Simeon-Rudolf V; Reiner E; Taylor P
Biochem J; 2003 Jul; 373(Pt 1):33-40. PubMed ID: 12665427
[TBL] [Abstract][Full Text] [Related]
23. Fluorescence-based sensing of p-nitrophenol and p-nitrophenyl substituent organophosphates.
Paliwal S; Wales M; Good T; Grimsley J; Wild J; Simonian A
Anal Chim Acta; 2007 Jul; 596(1):9-15. PubMed ID: 17616234
[TBL] [Abstract][Full Text] [Related]
24. A collaborative endeavor to design cholinesterase-based catalytic scavengers against toxic organophosphorus esters.
Masson P; Nachon F; Broomfield CA; Lenz DE; Verdier L; Schopfer LM; Lockridge O
Chem Biol Interact; 2008 Sep; 175(1-3):273-80. PubMed ID: 18508040
[TBL] [Abstract][Full Text] [Related]
25. Preparation and characterization of dialkylphosphoryl-obidoxime conjugates, potent anticholinesterase derivatives that are quickly hydrolyzed by human paraoxonase (PON1192Q).
Stenzel J; Worek F; Eyer P
Biochem Pharmacol; 2007 Nov; 74(9):1390-400. PubMed ID: 17714697
[TBL] [Abstract][Full Text] [Related]
26. The Relationship between PON1 phenotype and PON1-192 genotype in detoxification of three oxons by human liver.
Mutch E; Daly AK; Williams FM
Drug Metab Dispos; 2007 Feb; 35(2):315-20. PubMed ID: 17132760
[TBL] [Abstract][Full Text] [Related]
27. Amino acid residues involved in stereoselective inhibition of cholinesterases with bambuterol.
Bosak A; Gazić I; Vinković V; Kovarik Z
Arch Biochem Biophys; 2008 Mar; 471(1):72-6. PubMed ID: 18167304
[TBL] [Abstract][Full Text] [Related]
28. Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase.
Khersonsky O; Tawfik DS
Biochemistry; 2005 Apr; 44(16):6371-82. PubMed ID: 15835926
[TBL] [Abstract][Full Text] [Related]
29. Organophosphate hydrolases as catalytic bioscavengers of organophosphorus nerve agents.
Trovaslet-Leroy M; Musilova L; Renault F; Brazzolotto X; Misik J; Novotny L; Froment MT; Gillon E; Loiodice M; Verdier L; Masson P; Rochu D; Jun D; Nachon F
Toxicol Lett; 2011 Sep; 206(1):14-23. PubMed ID: 21683774
[TBL] [Abstract][Full Text] [Related]
30. Chromatographic preparation and kinetic analysis of interactions between tabun enantiomers and acetylcholinesterase.
Tenberken O; Thiermann H; Worek F; Reiter G
Toxicol Lett; 2010 Jun; 195(2-3):142-6. PubMed ID: 20347021
[TBL] [Abstract][Full Text] [Related]
31. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
[TBL] [Abstract][Full Text] [Related]
32. Interaction of pentylsarin analogues with human acetylcholinesterase: a kinetic study.
Worek F; Herkert NM; Koller M; Aurbek N; Thiermann H
Toxicol Lett; 2009 Jun; 187(2):119-23. PubMed ID: 19429253
[TBL] [Abstract][Full Text] [Related]
33. Chemical synthesis of two series of nerve agent model compounds and their stereoselective interaction with human acetylcholinesterase and human butyrylcholinesterase.
Barakat NH; Zheng X; Gilley CB; MacDonald M; Okolotowicz K; Cashman JR; Vyas S; Beck JM; Hadad CM; Zhang J
Chem Res Toxicol; 2009 Oct; 22(10):1669-79. PubMed ID: 19715346
[TBL] [Abstract][Full Text] [Related]
34. Stereochemical constraints on the substrate specificity of phosphotriesterase.
Hong SB; Raushel FM
Biochemistry; 1999 Jan; 38(4):1159-65. PubMed ID: 9930975
[TBL] [Abstract][Full Text] [Related]
35. Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects.
Sirivarasai J; Kaojarern S; Yoovathaworn K; Sura T
Chem Biol Interact; 2007 Jul; 168(3):184-92. PubMed ID: 17532308
[TBL] [Abstract][Full Text] [Related]
36. Unmasking tandem site interaction in human acetylcholinesterase. Substrate activation with a cationic acetanilide substrate.
Johnson JL; Cusack B; Davies MP; Fauq A; Rosenberry TL
Biochemistry; 2003 May; 42(18):5438-52. PubMed ID: 12731886
[TBL] [Abstract][Full Text] [Related]
37. Affinity binding-guided fluorescent nanobiosensor for acetylcholinesterase inhibitors via distance modulation between the fluorophore and metallic nanoparticle.
Zhang Y; Hei T; Cai Y; Gao Q; Zhang Q
Anal Chem; 2012 Mar; 84(6):2830-6. PubMed ID: 22339669
[TBL] [Abstract][Full Text] [Related]
38. Mutation of acetylcholinesterase to enhance oxime-assisted catalytic turnover of methylphosphonates.
Kovarik Z; Radić Z; Berman HA; Taylor P
Toxicology; 2007 Apr; 233(1-3):79-84. PubMed ID: 17046138
[TBL] [Abstract][Full Text] [Related]
39. Analogues with fluorescent leaving groups for screening and selection of enzymes that efficiently hydrolyze organophosphorus nerve agents.
Briseño-Roa L; Hill J; Notman S; Sellers D; Smith AP; Timperley CM; Wetherell J; Williams NH; Williams GR; Fersht AR; Griffiths AD
J Med Chem; 2006 Jan; 49(1):246-55. PubMed ID: 16392809
[TBL] [Abstract][Full Text] [Related]
40. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma.
Li B; Sedlacek M; Manoharan I; Boopathy R; Duysen EG; Masson P; Lockridge O
Biochem Pharmacol; 2005 Nov; 70(11):1673-84. PubMed ID: 16213467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
